Concepedia

David Monteith

DM

Statistics

Publications

34

Citations

1.9K

H-Index

21

Active since

1985

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Eli Lilly (United States)

Indiana University – Purdue University Fort Wayne

Duke Medical Center

The University of Texas Health Science Center at Houston

David Monteith is an author at Ionis Pharmaceuticals (United States) specializing in pharmacology, pharmacy, and toxicology.

Publications per year

1985–2018

34

Publications

34

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky et al. · Journal of Clinical Investigation · 2004 · 215 citations · Full text

, , +17

Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice

Scott P. Henry, Kim Stecker, Doug A. Brooks et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 146 citations

, , +15

In Vivo Distribution and Metabolism of a Phosphorothioate Oligonucleotide within Rat Liver after Intravenous Administration

Mark Graham, Stanley T. Crooke, David Monteith et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 139 citations

, , +17

Tissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys

Rosie Z. Yu, Richard S. Geary, David Monteith et al. · Journal of Pharmaceutical Sciences · 2003 · 106 citations

, , +9

Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer

Richard H. Griffey, Michael J. Greig, Hans Gaus et al. · Journal of Mass Spectrometry · 1997 · 96 citations

, , +16

1–5 of 34